BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai Q, Xu YH, Chen Q, Tang L, Li AG, Zhang LF, Zhang CF, Song JF, Du ZZ. The loss-of-function of DNA methyltransferase 1 by siRNA impairs the growth of non-small cell lung cancer with alleviated side effects via reactivation of RASSF1A and APC in vitro and vivo. Oncotarget 2017;8:59301-11. [PMID: 28938637 DOI: 10.18632/oncotarget.19573] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Bin Y, Ding Y, Xiao W, Liao A. RASSF1A: A promising target for the diagnosis and treatment of cancer. Clin Chim Acta 2020;504:98-108. [PMID: 31981586 DOI: 10.1016/j.cca.2020.01.014] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Peng Z, Zhou W, Zhang C, Liu H, Zhang Y. Curcumol Controls Choriocarcinoma Stem-Like Cells Self-Renewal via Repression of DNA Methyltransferase (DNMT)- and Histone Deacetylase (HDAC)-Mediated Epigenetic Regulation. Med Sci Monit 2018;24:461-72. [PMID: 29363667 DOI: 10.12659/msm.908430] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
3 Lin J, Zhuo Y, Yin Y, Qiu L, Li X, Lai F. Methylation of RILP in lung cancer promotes tumor cell proliferation and invasion. Mol Cell Biochem 2021;476:853-61. [PMID: 33128214 DOI: 10.1007/s11010-020-03950-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Hassanzadeh A, Farshdousti Hagh M, Alivand MR, Akbari AAM, Shams Asenjan K, Saraei R, Solali S. Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL. J Cell Physiol 2018;233:6470-85. [DOI: 10.1002/jcp.26585] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
5 Du M, Gong P, Zhang Y, Liu Y, Liu X, Zhang F, Wang X. Histone methyltransferase SETD1A participates in lung cancer progression. Thorac Cancer 2021;12:2247-57. [PMID: 34219384 DOI: 10.1111/1759-7714.14065] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Guo Y, Long J, Lei S. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis. J Cell Physiol 2019;234:7356-67. [PMID: 30370527 DOI: 10.1002/jcp.27495] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
7 McKenna S, García-Gutiérrez L. Resistance to Targeted Therapy and RASSF1A Loss in Melanoma: What Are We Missing? Int J Mol Sci 2021;22:5115. [PMID: 34066022 DOI: 10.3390/ijms22105115] [Reference Citation Analysis]
8 Chao YL, Pecot CV. Targeting Epigenetics in Lung Cancer. Cold Spring Harb Perspect Med 2021;11:a038000. [PMID: 32900703 DOI: 10.1101/cshperspect.a038000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Al-Yozbaki M, Jabre I, Syed NH, Wilson CM. Targeting DNA methyltransferases in non-small-cell lung cancer. Semin Cancer Biol 2021:S1044-579X(21)00011-0. [PMID: 33486076 DOI: 10.1016/j.semcancer.2021.01.005] [Reference Citation Analysis]
10 Zheng F, Zhao Y, Li X, Tang Q, Wu J, Wu W, Hann SS. The repression and reciprocal interaction of DNA methyltransferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib. J Ethnopharmacol 2019;239:111928. [PMID: 31077779 DOI: 10.1016/j.jep.2019.111928] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]